BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mei J, Duan H, Wang L, Yang S, Lu J, Shi T, Zhao Y. XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis. Tumor Biol 2014;35:1221-31. [DOI: 10.1007/s13277-013-1163-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Meng Q, Wang S, Tang W, Wu S, Gao N, Zhang C, Cao X, Li X, Zhang Z, Aschner M, Jin H, Huang Y, Chen R. XRCC1 mediated the development of cervival cancer through a novel Sp1/Krox-20 swich. Oncotarget 2017;8:86217-26. [PMID: 29156789 DOI: 10.18632/oncotarget.21040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Charles MR, Raza ST, Sharma R, Pratap P, Eba A, Singh M. Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population. Asian Pac J Cancer Prev 2020;21:2061-5. [PMID: 32711433 DOI: 10.31557/APJCP.2020.21.7.2061] [Reference Citation Analysis]
3 Liu GC, Zhou YF, Su XC, Zhang J. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study. BMC Cancer 2019;19:24. [PMID: 30616520 DOI: 10.1186/s12885-018-5149-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zeng X, Zhang Y, Yue T, Zhang T, Wang J, Xue Y, An R. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects. Oncotarget 2017;8:2249-60. [PMID: 27903984 DOI: 10.18632/oncotarget.13663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Hasan ME, Matin M, Haque ME, Aziz MA, Millat MS, Uddin MS, Moghal MMR, Islam MS. Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women. Cancer Med 2021;10:1829-38. [PMID: 33586351 DOI: 10.1002/cam4.3782] [Reference Citation Analysis]
6 Mei PJ, Bai J, Miao FA, Li ZL, Chen C, Zheng JN, Fan YC. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma. Invest New Drugs 2019;37:646-57. [PMID: 30328556 DOI: 10.1007/s10637-018-0667-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
7 Chen D, Gyllensten U. Lessons and implications from association studies and post-GWAS analyses of cervical cancer. Trends Genet. 2015;31:41-54. [PMID: 25467628 DOI: 10.1016/j.tig.2014.10.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
8 Yang NN, Huang YF, Sun J, Chen Y, Tang ZM, Jiang JF. Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer. Oncotarget 2017;8:28455-62. [PMID: 28415705 DOI: 10.18632/oncotarget.16090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kuguyo O, Tsikai N, Thomford NE, Magwali T, Madziyire MG, Nhachi CFB, Matimba A, Dandara C. Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers? OMICS 2018;22:468-83. [PMID: 30004844 DOI: 10.1089/omi.2018.0075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]